Roche to Cut Jobs in SF2.4 Billion Cost-Reduction
This article is for subscribers only.
Roche Holding AG, the world’s biggest maker of cancer medicines, will cut 4,800 jobs in a 2.4-billion Swiss franc ($2.4 billion) cost-reduction plan to offset the impact of health reform and drug setbacks.
The plan will affect about 6 percent of Roche employees, mostly in the pharmaceutical division, and lead to costs of about 2.7 billion francs through 2012, the Basel, Switzerland- based company said today in a statement. Employment will be cut in Nutley, New Jersey; Madison, Wisconsin; Graz, Austria, and Burgdorf, Switzerland, among other sites.